{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:50:24Z","timestamp":1785685824311,"version":"3.56.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clindermatol.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T19:50:40Z","timestamp":1585597840000},"page":"432-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genodermatoses with malignant potential"],"prefix":"10.1016","volume":"38","author":[{"given":"Ryan","family":"Ladd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.03.007_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0010","series-title":"Genetic Predisposition to Cancer","first-page":"193","article-title":"The Gorlin (nevoid basal cell carcinoma) syndrome","author":"Farndon","year":"2004"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0015","series-title":"GeneReviews","article-title":"Nevoid basal cell carcinoma syndrome","author":"Evans","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jmg.30.6.460","article-title":"Complications of the naevoid basal cell carcinoma syndrome: results of a population based study","volume":"30","author":"Evans","year":"1993","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0030","doi-asserted-by":"crossref","unstructured":"Bree AF, Shah MR; BCNS Colloquium Group. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet A. 2011;155:2091-2097.","DOI":"10.1002\/ajmg.a.34128"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0035","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-17-0595","article-title":"Cancer surveillance in Gorlin syndrome and rhabdoid tumor predisposition syndrome","volume":"23","author":"Foulkes","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10689-014-9712-9","article-title":"Intronic splicing mutations in PTCH1 cause Gorlin syndrome","volume":"13","author":"Bholah","year":"2014","journal-title":"Familial Cancer"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0045","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2014.58.2569","article-title":"Germline mutations in SUFU cause Gorlin syndrome\u2013associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations","volume":"32","author":"Smith","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jmedgenet-2017-104669","article-title":"First evidence of genotype\u2013phenotype correlations in Gorlin syndrome","volume":"54","author":"Evans","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.33.3.357","article-title":"Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival","volume":"33","author":"J\u00e4rvinen","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0060","first-page":"139","article-title":"Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis","volume":"5","author":"Gardner","year":"1953","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00000478-200105000-00012","article-title":"Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis","volume":"25","author":"Wehrli","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0070","series-title":"Familial Polyposis Coli: Family Studies, Histopathology, Differential Diagnosis, and Results of Treatment","author":"Bussey","year":"1975"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0075","series-title":"APC-associated polyposis conditions. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Jasperson","year":"1998"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2006.07.004","article-title":"Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature","volume":"61","author":"Nieuwenhuis","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/jcmm.13303","article-title":"A novel mutation of adenomatous polyposis coli (APC) gene results in the formation of supernumerary teeth","volume":"22","author":"Yu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/11311180-000000000-00000","article-title":"Gardner syndrome: skin manifestations, differential diagnosis and management","volume":"11","author":"Juhn","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0100","doi-asserted-by":"crossref","first-page":"21483","DOI":"10.18632\/oncotarget.15277","article-title":"Lynch syndrome-related small intestinal adenocarcinomas","volume":"8","author":"Jun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0105","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.3748\/wjg.v21.i31.9253","article-title":"Lynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancer","volume":"21","author":"Carethers","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0110","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMcp1714533","article-title":"Lynch syndrome\u2013associated colorectal cancer","volume":"379","author":"Sinicrope","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0115","first-page":"442","article-title":"Ponz de Leon M, Maffei S, et al","volume":"68","author":"Ponti","year":"2005","journal-title":"Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations Clin Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0190-9622(99)70001-0","article-title":"Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature","volume":"41","author":"Akhtar","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaad.2015.09.074","article-title":"Muir-Torre syndrome (MTS): an update and approach to diagnosis and management","volume":"74","author":"John","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0130","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/PAS.0b013e31815b0cc2","article-title":"Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia","volume":"32","author":"Singh","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0135","first-page":"259","article-title":"Analysis of sebaceous neoplasms for DNA mismatch repair proteins in Muir-Torre Syndrome","volume":"15","author":"Pollinger","year":"2017","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0140","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1470-2045(05)70465-4","article-title":"Muir-Torre syndrome","volume":"6","author":"Ponti","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.sempedsurg.2014.03.008","article-title":"Multiple endocrine neoplasia (MEN) syndromes","volume":"23","author":"Walls","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.soc.2015.06.008","article-title":"Multiple endocrine neoplasia: genetics and clinical management","volume":"24","author":"Norton","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0155","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cup.12643","article-title":"Multiple cutaneous collagenomas in the setting of multiple endocrine neoplasia type 1","volume":"42","author":"P\u00e9rez","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0160","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Walls","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.lpm.2018.03.005","article-title":"Update on multiple endocrine neoplasia Type 1 and 2","volume":"47","author":"Al-Salameh","year":"2018","journal-title":"Presse Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0170","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imj.12925","article-title":"Cutaneous lichen amyloidosis in multiple endocrine neoplasia","volume":"46","author":"De Sousa","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0180","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jamadermatol.2017.3959","article-title":"Dermal hyperneury and multiple sclerotic fibromas in multiple endocrine neoplasia type 2A syndrome","volume":"153","author":"Alegria-Landa","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5021\/ad.2010.22.4.452","article-title":"Multiple endocrine neoplasia type 2B: early diagnosis by multiple mucosal neuroma and its DNA analysis","volume":"22","author":"Lee","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0190","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: an update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11154-016-9400-1","article-title":"Carney complex: a familial lentiginosis predisposing to a variety of tumors","volume":"17","author":"Stratakis","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0200","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jocs.12575","article-title":"Medical and surgical management of Carney complex","volume":"30","author":"Siordia","year":"2015","journal-title":"J Card Surg"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0","article-title":"Mutations of the human PTEN gene","volume":"16","author":"Bonneau","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/GIM.0b013e3181ac9aea","article-title":"PTEN hamartoma tumor syndrome: an overview","volume":"11","author":"Hobert","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12105-016-0708-7","article-title":"Genodermatosis affecting the skin and mucosa of the head and neck: clinicopathologic, genetic, and molecular aspect\u2014PTEN-hamartoma tumor syndrome\/Cowden Syndrome","volume":"10","author":"Nose","year":"2016","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0220","series-title":"Atlas of Genodermatoses","first-page":"498","article-title":"Genodermatoses related to malignancy","author":"Tadini","year":"2015"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0225","series-title":"PTEN hamartoma tumor syndrome. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Eng","year":"2016"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0230","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the real Cowden syndrome please stand up: revised diagnostic criteria","volume":"37","author":"Eng","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0235","series-title":"Hereditary leiomyomatosis and renal cell cancer. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Pithukpakorn","year":"2015"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41589-018-0217-y","article-title":"A chemoproteomic portrait of the oncometabolite fumarate","volume":"15","author":"Kulkarni","year":"2019","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jdcr.2017.06.007","article-title":"Treatment of cutaneous leiomyomas with 5% lidocaine patches in a patient with hereditary leiomyomatosis and renal cell cancer (Reed syndrome)","volume":"3","author":"Hsu","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0250","series-title":"Birt-Hogg-Dub\u00e9 syndrome. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Toro","year":"2014"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0255","series-title":"Andrews\u2019 Diseases of the Skin: Clinical Dermatology","author":"James","year":"2011"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0260","series-title":"Neurofibromatosis 1. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Friedman","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0265","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0270","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archdermatol.2009.169","article-title":"Predictive value of caf\u00e9 au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1 predictive value of caf\u00e9 au lait macules of NF1","volume":"145","author":"Nunley","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0275","doi-asserted-by":"crossref","first-page":"e35711","DOI":"10.1371\/journal.pone.0035711","article-title":"Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis","volume":"7","author":"Plotkin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000368078","article-title":"Treatment of neurofibromas with a carbon dioxide laser: a retrospective cross-sectional study of 106 patients","volume":"230","author":"M\u00e9ni","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0285","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-0034-1382021","article-title":"Neurofibromatosis type 1 (NF1) and associated tumors","volume":"226","author":"Rosenbaum","year":"2014","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0290","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/gim.2018.28","article-title":"Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Stewart","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0295","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0305","series-title":"Neurofibromatosis 2. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Evans","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0310","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk of mortality in neurofibromatosis 2","volume":"71","author":"Baser","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0315","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0320","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pcl.2015.03.005","article-title":"Tuberous sclerosis complex","volume":"62","author":"DiMario","year":"2015","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0325","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-444-62702-5.00006-8","article-title":"Chapter 6: tuberous sclerosis complex","volume":"132","author":"Islam","year":"2015"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0335","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/archdischild-2016-312001","article-title":"Cutaneous manifestations of tuberous sclerosis complex and the paediatrician\u2019s role","volume":"102","author":"Cardis","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0340","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0345","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0350","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamadermatol.2018.0464","article-title":"Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex: the TREATMENT Randomized Clinical Trial","volume":"154","author":"Koenig","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0355","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jamadermatol.2014.4298","article-title":"Clinical and histologic analysis of the efficacy of topical rapamycin therapy against hypomelanotic macules in tuberous sclerosis complex","volume":"151","author":"Wataya-Kaneda","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","article-title":"Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex","volume":"20","author":"Salussolia","year":"2019","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0365","series-title":"Peutz Jeghers syndrome. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"McGarrity","year":"2016"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0370","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jmg.2003.010900","article-title":"Genotype\u2013phenotype correlations in Peutz-Jeghers syndrome","volume":"41","author":"Amos","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0375","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/gut.2009.198499","article-title":"Peutz\u2013Jeghers syndrome: a systematic review and recommendations for management","volume":"59","author":"Beggs","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0380","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ajg.2010.473","article-title":"High cumulative risk of intussusception in patients with Peutz-Jeghers syndrome: time to update surveillance guidelines?","volume":"106","author":"van Lier","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0385","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.dld.2012.12.018","article-title":"Cancer risk associated with STK11\/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study","volume":"45","author":"Resta","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0390","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gie.2011.04.001","article-title":"Nonsurgical management of small-bowel polyps in Peutz-Jeghers syndrome with extensive polypectomy by using double-balloon endoscopy","volume":"74","author":"Sakamoto","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0395","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ajog.2017.04.011","article-title":"Current and future role of genetic screening in gynecologic malignancies","volume":"217","author":"Ring","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0400","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12105-016-0707-8","article-title":"Xeroderma pigmentosum","volume":"10","author":"Black","year":"2016","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0405","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/jid.2011.426","article-title":"Shining a light on xeroderma pigmentosum","volume":"132","author":"DiGiovanna","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0410","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/1346-8138.13907","article-title":"Xeroderma pigmentosum clinical practice guidelines","volume":"44","author":"Moriwaki","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0415","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ophtha.2012.12.044","article-title":"Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage","volume":"120","author":"Brooks","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0420","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-6-70","article-title":"Xeroderma pigmentosum","volume":"6","author":"Lehmann","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0425","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/php.12345","article-title":"Forty years of research on xeroderma pigmentosum at the US National Institutes of Health","volume":"91","author":"Kraemer","year":"2015","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0430","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(00)04214-8","article-title":"Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study","volume":"357","author":"Yarosh","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0435","series-title":"Bloom\u2019s syndrome. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Sanz","year":"2019"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0440","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000452082","article-title":"Bloom\u2019s syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition","volume":"8","author":"Cunniff","year":"2017","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0445","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4103\/ijo.IJO_89_17","article-title":"Ophthalmic manifestations in Rothmund-Thomson syndrome: case report and review of literature","volume":"65","author":"Chinmayee","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0450","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1172-5-2","article-title":"Rothmund-Thomson syndrome","volume":"5","author":"Larizza","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0455","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","article-title":"Ataxia-telangiectasia: immunodeficiency and survival","volume":"178","author":"van Os","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0460","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0465","doi-asserted-by":"crossref","unstructured":"Reliene R, Schiestl RH. Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice. J Nutr. 2007;137(suppl):229s-232s.","DOI":"10.1093\/jn\/137.1.229S"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0470","first-page":"431","article-title":"Experimental antioxidant therapy in ataxia telangiectasia","volume":"2","author":"Reliene","year":"2008","journal-title":"Clin Med Oncol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0475","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0480","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","article-title":"Dyskeratosis congenita","volume":"2011","author":"Dokal","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0485","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1468-3083.2003.00585.x","article-title":"Dyskeratosis congenita associated with three malignancies","volume":"17","author":"Baykal","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0490","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MOH.0000000000000290","article-title":"Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita","volume":"23","author":"Elmahadi","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0495","doi-asserted-by":"crossref","unstructured":"Gaytan de Ayala Alonso A, Gutierrez L, Fritsch C, et al. A genetic screen identifies novel polycomb group genes in Drosophila. Genetics. 2007;176:2099-2108.","DOI":"10.1534\/genetics.107.075739"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0500","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0505","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0510","unstructured":"Bundra K, Akin C. Mastocytosis. In: Rare Disease Database 2017. Available at: https:\/\/rarediseases.org\/rare-diseases\/mastocytosis\/. Accessed on 5\/12\/20."},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0515","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0520","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.iac.2018.04.005","article-title":"Kit mutations: new insights and diagnostic value","volume":"38","author":"Falchi","year":"2018","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0525","first-page":"36","article-title":"Raising awareness among healthcare providers about epidermolysis bullosa and advancing toward a cure","volume":"10","author":"Tabor","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0530","doi-asserted-by":"crossref","first-page":"428","DOI":"10.12968\/bjon.2016.25.8.428","article-title":"Diagnosis, treatment and management of epidermolysis bullosa","volume":"25","author":"Watkins","year":"2016","journal-title":"Br J Nurs"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0545","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.14104","article-title":"Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines","volume":"174","author":"Mellerio","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0555","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000479036","article-title":"A rare syndrome resembling scleroderma: Huriez syndrome","volume":"4","author":"Celik","year":"2018","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0560","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2229-5178.148929","article-title":"Poikiloderma a varied presentation\u2014Huriez syndrome","volume":"6","author":"Kharge","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0565","first-page":"3","article-title":"Huriez syndrome: a rare palmoplantar keratoderma","volume":"4","author":"Kumar","year":"2017","journal-title":"Int J Res Med Sci"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0570","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jid.2018.01.015","article-title":"SMARCAD1 haploinsufficiency underlies Huriez syndrome and associated skin cancer susceptibility","volume":"138","author":"Gunther","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0575","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-015-0346-2","article-title":"Tylosis with oesophageal cancer: diagnosis, management and molecular mechanisms","volume":"10","author":"Ellis","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0580","doi-asserted-by":"crossref","unstructured":"Ellis A, Field JK, Field EA, et al. Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family\u2014a review of six generations. Eur J Cancer B Oral Oncol. 1994;30b:102-112.","DOI":"10.1016\/0964-1955(94)90061-2"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0585","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajhg.2011.12.008","article-title":"RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome","volume":"90","author":"Blaydon","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0590","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0595","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng1493","article-title":"Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity","volume":"37","author":"Descargues","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0600","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Freedberg","year":"2003"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0605","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0610","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13023-018-0956-6","article-title":"Immune cell phenotype and functional defects in Netherton syndrome","volume":"13","author":"Er\u00e4nk\u00f6","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0615","first-page":"345","article-title":"Multiple epitheliomata cuniculata occurring in a mutilating keratoderma","volume":"35","author":"Barnett","year":"1985","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0620","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1365-2133.2001.04453.x","article-title":"A further case of plantar squamous cell carcinoma arising in Olmsted syndrome","volume":"145","author":"Yoshizaki","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0625","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13023-015-0246-5","article-title":"Olmsted syndrome: clinical, molecular and therapeutic aspects","volume":"10","author":"Duchatelet","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0630","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D393B7M0DQ","article-title":"Keratitis-ichthyosis-deafness (KID) syndrome","volume":"15","author":"Gonzalez","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0635","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12723","article-title":"Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome","volume":"287","author":"Su","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0640","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options\u2014a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0645","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/asheducation-2017.1.242","article-title":"Pediatric leukemia susceptibility disorders: manifestations and management","volume":"2017","author":"McReynolds","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0650","series-title":"Fanconi anemia. In: Adam MP, Ardinger HH, Pagon RL, eds. GeneReviews","author":"Mehta","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0655","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajh.24373","volume":"91","author":"Svahn","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0660","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0665","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood-2016-09-687889","article-title":"GATA factor mutations in hematologic disease","volume":"129","author":"Crispino","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0670","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0675","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000073082","article-title":"What is poikiloderma?","volume":"207","author":"Lipsker","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0680","series-title":"Rook\u2019s Textbook of Dermatology","article-title":"Poikiloderma syndromes","author":"Irvine","year":"2016"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0685","series-title":"GeneReviews","article-title":"Poikiloderma with neutropenia","author":"Wang","year":"2017"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0690","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajhg.2012.01.007","article-title":"Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome","volume":"90","author":"Tanaka","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0695","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.oraloncology.2016.12.009","article-title":"ATR gene mutations in HPV negative oropharyngeal cancer","volume":"65","author":"Jeannon","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0700","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.arr.2016.03.002","article-title":"Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions","volume":"33","author":"Oshima","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0705","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/acel.12190","article-title":"Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts","volume":"13","author":"Saha","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0720","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2015.08.038","article-title":"Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome","volume":"74","author":"Soura","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0725","doi-asserted-by":"crossref","unstructured":"Ipenburg NA, Gruis NA, Bergman W, et al. The absence of multiple atypical nevi in germline CDKN2A mutations: comment on \u201cHereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome.\u201d J Am Acad Dermatol 2016;75:e157.","DOI":"10.1016\/j.jaad.2016.04.069"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0730","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10689-016-9888-2","article-title":"Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity","volume":"15","author":"Lynch","year":"2016","journal-title":"Familial Cancer"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0735","series-title":"Cancer Syndromes [Internet]","article-title":"Familial Atypical Multiple Mole Melanoma Syndrome","author":"Eckerle Mize","year":"2009"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0740","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jhg.2015.114","article-title":"Recent advances in RASopathies","volume":"61","author":"Aoki","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0745","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40142-016-0100-7","article-title":"Expansion of the RASopathies","volume":"4","author":"Tidyman","year":"2016","journal-title":"Curr Genet Med Rep"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0750","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0755","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2133.2011.10744.x","article-title":"Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development","volume":"166","author":"Siegel","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.03.007_bb0760","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/bjd.16435","article-title":"Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma","volume":"179","author":"Prieto-Barrios","year":"2018","journal-title":"Br J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20300444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20300444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:15:47Z","timestamp":1760033747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20300444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0738081X20300444"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.03.007","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genodermatoses with malignant potential","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}